Health Care & Life Sciences » Pharmaceuticals | Alfresa Holdings Corp.

Alfresa Holdings Corp. | Ownership

Companies that own Alfresa Holdings Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Marathon Asset Management LLP
10,832,280
4.61%
-2,386,200
0.82%
08/31/2017
BlackRock Fund Advisors
7,243,692
3.08%
1,605,764
0.01%
01/31/2018
The Vanguard Group, Inc.
4,480,125
1.91%
50,600
0%
07/31/2018
Nomura Asset Management Co., Ltd.
4,105,797
1.75%
98,553
0.06%
07/31/2018
BlackRock Japan Co., Ltd.
3,835,700
1.63%
379,600
0.12%
01/31/2018
Norges Bank Investment Management
2,303,699
0.98%
-474,536
0.01%
12/31/2017
Deutsche Asset Management (UK) Ltd. (Investment Management)
1,959,057
0.83%
-166,100
0.09%
09/06/2018
Daiwa Asset Management Co. Ltd.
1,918,200
0.82%
36,400
0.06%
07/31/2018
Nikko Asset Management Co., Ltd.
1,735,299
0.74%
-102,801
0.03%
09/03/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
925,055
0.39%
24,155
0.05%
07/31/2018

About Alfresa Holdings

View Profile
Address
Ote Center Building, 23/F
Tokyo Tokyo 100
Japan
Employees -
Website http://www.alfresa.com
Updated 07/08/2019
Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions.